The global market for Precision Medicine Research and Development Platform was valued at USD 84730 Million in the year 2024 and is projected to reach a revised size of USD 120230 Million by 2031, ...
Wholly-owned laboratory has received CLIA certification from Massachusetts with full license to conduct patient testing and develop companion ...
UPPSALA, Sweden, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (OLK) today announced an agreement with Regeneron Genetics Center® (RGC) focused on the use and development of Olink ...
New AI-enabled data collection platform will drive the development of novel multimodal datasets for biomarker discovery, treatment-response modeling, and foundation models of the immune system ...
Quantum-Si Inc (NASDAQ:QSI) shares tanked over 12.8% Thursday morning. The company plans to introduce Platinum Pro, an advanced version of its Platinum platform, in the first half of 2025. Platinum ...
Bruker Corporation BRKR recently announced a new technology, EpicIF (Enhanced photobleaching in cyclic immunofluorescence), to further enhance the CellScape Precise Spatial Proteomics platform for ...
Industry leaders describe how proteomics is shifting toward clinical and applied use through standardized workflows, scalable ...
Zifo and Maze Therapeutics are partnering to develop solutions to manage, store, and scale massive and often disparate ...
SEATTLE, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NAUT) (NASDAQ: NAUT; or “Nautilus”), a company pioneering single-molecule proteome analysis, today announced the launch of an ...
SAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Yatiri Bio, Inc., a leader in proteomics-driven precision medicine, today announced the successful acquisition of NGeneBioAI, Inc., a San Diego-based ...
Affinity-based protein analysis tools have become increasingly scalable, expanding their established use in low-plex settings. Nomic is the latest entrant in this space with its nELISA™ technology, ...
-- AIMS (TM) Platform validated: Integration of AI-driven structural modeling with mass-spectrometry-based structural proteomics, which supported the lead optimization of the KAT6A Targeted Protein ...